Recent Insights
Article
December 17, 2025
The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.
26:26
Speakers: Jason Callaham, Joseph Hennessee
Understand targeted populations in NMTC deals and learn how nonprofits, businesses, and investors can leverage tax credits for community projects.
Case Study
December 9, 2025
See how Cherry Bekaert's SFS team secured allocation to help the Food Bank of Central & Eastern North Carolina's Wilmington branch add capacity.
Article
July 25, 2025
Updated: December 8, 2025
Starting in the 2025 tax year, the Section 174 repeal lets businesses immediately deduct domestic R&E expenditures. Explore what else is changing.
33:49
Speakers: Sarah McGregor, Brooks E. Nelson, Kasey Pittman
Explore 2025 tax reform changes, IRS operations during shutdowns, and economic trends shaping planning decisions for businesses and individuals.
Article
February 5, 2025
Updated: December 4, 2025
Explore the implications of Virginia’s R&D tax credit sunset on strategic tax planning and gain insights into the 2026 outlook for its potential revival.
Alert
December 4, 2025
Explore how Washington's Voluntary Disclosure Program (VDP) gives unregistered international sellers a limited-time opportunity to come into compliance.
Alert
December 1, 2025
The FDIC approved a final rule updating certain regulatory thresholds to reflect inflation. Discover the relief this offers to community banks.
Article
November 25, 2025
The preclinical drug development stage involves determining a drug's safety profile and pursuing Series A funding. Explore the requirements in our guide.
Article
November 20, 2025
Learn about IRS rules and tax strategies property owners can use to reduce audit risk and maximize tax deductions.